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Abstract 
In the present study herbal products marketed in Yavatmal India were determined for the presence of 
microbial. Microbial contents in herbal products were examined as suggested in as per W.H.O. The total of ten 
herbal products of various brands were selected randomly and tested for microbial contamination. Of which 3 
samples did not conform to the W.H.O guidelines. The formulations are used daily by the patients suffering 
from Liver diseases. The specific medias were used to determining the presence of Escherichia coli (4 
samples), Staphylococcus aureus (3 samples), and P. aeruginosa (4 samples). The data indicated suggest that 
there is requirement of in process improvement to provide better quality for consumer health in order to be 
competitive in international markets. 
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1. Introduction 
Herbal medicines are plant derived materials 
and preparations with therapeutic or other human 
health benefits, which contain either raw or processed 
ingredients from one or more plants, inorganic 
materials or animal origin. Herbal medicine 
preparations are developed and created drugs by the 
modern pharmaceutical industry. Nowadays, they are 
manufactured and sold most widely on the 
pharmaceutical market for curing diseases and 
promoting public health worldwide.1 
 Herbal drugs have been used since ancient 
times as remedies and treatment for a range of 
diseases. Western pharmaceutical drugs play a major 
role in modern medicine, but traditional medicine 
are used by approximately 60% of people in rural 
areas still make an important contribution in health 
care.2 
In India, the unscientific methods of 
collection, storage, transportation and congenial 
climatic conditions make the raw materials of herbal 
drugs prone to fungal infestations. The raw materials 
are collected using unscientific methods and are 
commonly exposed to many microbial contaminants. 
The raw materials are often deteriorated by 
microorganisms before harvesting, and during 
handling and storage.3 
The liver performs the normal metabolic 
homeostasis of the body as well as 
biotransformation, detoxification and excretion of 
many endogenous and exogenous compounds, 
including pharmaceutical and environmental 
chemicals. Drug-induced hepatotoxicity is a major 
cause of iatrogenic diseases, accounting for one in 
600 to one in 3500 of all hospital admissions.4 
The microbial quality of pharmaceuticals is 
influenced by the environment and quality of the raw 
materials used during formulation. Some infectious 
outbreaks have been associated with the use of 
heavily contaminated raw materials of natural origin. 
 
Table No.1 W.H.O. Limits for microbial 
contamination5 
Microorganism Finished product Cfu 
Escherichia coli 101/gm 
Staphylococus.aureus 105/gm 
Pseudomonas aeruginosa 103  /gm 
Salmonella species. Nil 
1.1 Sources of contaminations in herbal products.   
The practices of most ethnic herbal medicine 
include the use crude or raw herbs that are collected 
from the wild or from cultivated fields and their 
prepared or ready-made products.  
Toxic contaminants may come from: 
• Environments and conditions that the 
medicinal plants are grown or collected 
• The conditions under which they are dried and 
processed. 
• The storage conditions and conditions during 
transport. 
• Unhygienic use  of medicines by patients 
• The manufacturing processes when the ready-
made medicinal products are produced.6 
 
2.0 Marketed Formulations Selected for 
Study 
Hepatoprotective formulations ie churna of 
10 different marketed brands were selected for study. 
It consist of Carduus marianus, Chelidonium majus, 
Taraxacum officinale, hionanthus virginica, Quassia 
amara, Heparbovinum, Ceanothus americanus, 
Colocynthis, Leptandra virginica, Natrum 
sulphuricum, Nux vomica, Phosphorus,Teucrium 
marum 
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3. Experimental Work 
3.1 Sample collection  
The ten herbal formulations of 
Hepatoprotective formulations marketed by various 
herbal manufacturers were collected from the retail 
medical stores of Yavatmal (Vidarbha region, India). 
The formulation code were given to selected 
formulation as HP1 to HP10 
3.2 Materials & methods  
 Serial dilutions were made and viability 
assessed using the pour plate method. The plates were 
incubated at 37oC for 24h. The plate was placed on a 
colony counter and the number of colony forming 
units was taken. The microbial content was taken as 
the mean of duplicate determinations. The media 
utilized were Nutrient agar, Cetrimide Nutrient agar, 
Salt Nutrient agar, MacConkey agar7 
3.3 Pathogen determination 
3.3.1 Determination of S. aureus 
 10 mg of the sample was added into Tryptic 
soya broth and incubated at 37oC for 24 hours. The 
sample was then streaked on Vogel- Johnson agar and 
incubated at 37oC for 24 hours. A single colony on 
each plate was then resteaked on Mannitol salt agar 
and incubated at 37oC for 24 hours. After the 
incubation, the colonial morphology was observed .8 
The results are expressed in Table No.2 and Figure 
No.1 
3.3.2 Determination of Escherichia coli  
 Suspend 10 gm of the specimen in lactose 
broth or any other broth, which has no antibacterial 
effect to make 100ml (may adjust PH at 7). It is called 
pretreatment material Incubate 100ml of pretreatment 
material at 30-37°C for 2-5 hrs. Transfer amount of 
above homogenized pretreatment material containing 
1gm or 1ml of the material being examined to 100ml 
of MacConkey broth and incubate at 43-45c for 18-
24hrs Prepare subculture on a plate with MacConkey 
agar and incubate at 43-45c for 18-24hrs Growth of 
red generally non-mucoid colonies of Gram-negative 
rods, sometimes surrounded by.a reddish zone of 
precipitation, indicates the possible presence of 
E.coli.9 
The results are expressed in Table No.2 and 
Figure No.2 
3.3.3 Determination of P. aeruginosa 
 The diluted sample was streaked onto 
Cetrimide agar plate. After the incubation at 37oC for 
24 hours, the green colonies were tested for oxidase 
reaction and subcultured into Triple sugar iron 
medium. Growth of bacteria and the reaction results 
were observed.10 
The results are expressed in Table No.2 and 
Figure No.3 
 
4.0 Results  
Table No.2 Comparative detrmination of microbial contamination in Hepatoproective formulations 
Sr.No Formulation code 
Pseudomonas aeroginosa 
(103 cfu /gm) 
Escherichia coli 
(10cfu/gm) 
Staphylococcus aureus 
(105cfu/gm) 
1 HP1 5 x 102 - 8 x 104 
2 HP 2 7 x 102 - 7 x 104 
3 HP 3 6 x 102 -  5 x 104 
4 HP 4 3 x 102 - 6 x 104 
5 HP 5 12 x 102 2 X 10 13 x 104 
6 HP 6 6 x 102 - 15 x 104 
7 HP 7 13 x 102 4 x 10 9  x 104 
8 HP 8 14 x 102 1 x 10 7  x 104 
9 HP 9 15 x 102 3 x 10 14  x 104 
10 HP 10 6 x 102 - 6 x 104 
 
Figure No.1: Pseudomonas aeruginosa content in Hepatoprotective formulations 
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Figure No.2: Escherichia Coli content in Hepatoprotective formulations 
 
Figure No.3: Staphylococcus aureus content in Hepatoprotective formulations 
 
 
5.0 Discussion 
The present study reports microbial 
contaminations in herbal products widely distributed 
over the country. It was found that the formulations 
code HP5, HP 7, HP8 and HP9 were contaminated by 
Pseudomonas aeruginosa and HP5, HP 7, HP8 and 
HP9 were contaminated by Escherichia coli whereas 
the formulations having code no.HP5, HP6 and HP9 
were contaminated by Staphylococcus aureus more 
than the limit prescribed by WHO if such product was 
consumed by patient there was possibility of 
infection. Medicinal plants have been generally used 
for decades. Consumers can easily acquire pathogenic 
microorganisms by consuming contaminated 
products. The results from this study suggest that the 
production of herbal products is still in critical 
situation in terms of quality and safety. Very low 
product quality can be derived from many factors 
such as cultivation, harvest, manufacturing procedure, 
transportation, and storage. The good handling must 
be carried out starting from raw materials to finished 
products. 
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